Indianapolis, IN — While billions of people all over the world use pharmaceuticals to live longer and better lives, the vast majority of us know very little about how the pill in our medicine cabinet came to be there. To remedy this, Eli Lilly and Company recently posted dozens of attention grabbing infographics here ( that share facts from their wealth of information around clinical trials. They range from high level participant satisfaction data (“95% of people who have participated in a clinical trial say they would participate in another one”) to deeper personal insights (“Top 2 reasons people join a clinical trial: 1. To help advance science 2. To help others”). All these facts humanize a very clinical process and help reinforce the value of the work that Lilly does. If anyone’s interest is piqued, readers can click on several links to take them directly to the clinical trials page to learn more or even find a trial to join.


Why This Matters –


In our age of Big Data and little attention spans, Lilly has wisely provided valuable information to anyone interested that also subtly begs them to dive deeper or even participate in clinical trials. Understanding the current state of new drug development is essential as the future of the approval process in the US will be in flux as Real World Data, EMR, Apple’s HealthKit, and countless other progressive elements converge.

About the Author:

Drew Beck has spent his entire career in healthcare — from direct patient care as an EMT in college to countless roles in pharma sales and global marketing for leading life science companies including Eli Lilly & Co. and GlaxoSmithKline. He is currently a leader on the Syneos Health Insights & Innovation team, a group charged with leveraging deep expertise in virtual collaboration, behavioral science, trends-based-innovation, custom research and global marketing insights.